Phosphorylated ITIMs Enable Ubiquitylation of an Inhibitory Cell Surface Receptor
- 6 December 2007
- Vol. 9 (2), 267-279
- https://doi.org/10.1111/j.1600-0854.2007.00682.x
Abstract
Immune responses are modulated by activating and inhibitory receptors that traffic to and from the cell surface. Ligands that bind to inhibitory receptors induce phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in their cytoplasmic tails, followed by recruitment of inhibitory signaling molecules. Mechanisms that control the surface levels of inhibitory receptors are largely unexplored. Here, we show, using CD33/sialic acid-binding immunoglobulin-like lectin (Siglec)-3 as a paradigm, that ITIMs can bind to the ubiquitin ligase Cbl and that ITIMs are ubiquitylated following Src family kinase-mediated tyrosine phosphorylation. Ubiquitylation is a known signal for endocytosis. Accordingly, cells expressing CD33 mutants that cannot become ubiquitylated show significantly increased cell surface expression of CD33 and have impaired CD33 internalization, whereas in-frame fusion of ubiquitin to CD33 reverses this phenotype. Our results identify a novel function of ITIMs and demonstrate that phosphorylation-dependent ubiquitylation regulates cell surface expression and internalization, and thus possibly function, of CD33/Siglec-3, suggesting an important role of ubiquitin in endocytosis of ITIM-bearing inhibitory immunoreceptors.Keywords
This publication has 57 references indexed in Scilit:
- Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate ImmunityMolecular and Cellular Biology, 2007
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Siglecs in innate immunityCurrent Opinion in Pharmacology, 2005
- Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3‐kinase‐mediated intracellular signalingEuropean Journal of Immunology, 2004
- Ubiquitin Ligases and the Immune ResponseAnnual Review of Immunology, 2004
- New agents in acute myeloid leukemia and other myeloid disordersCancer, 2004
- c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulationNature Immunology, 2002
- Immune Inhibitory ReceptorsScience, 2000
- cbl-b inhibits epidermal growth factor receptor signalingOncogene, 1999
- Propagation of large numbers of cells of a human mixed‐lineage T‐lymphoid/myeloidBritish Journal of Haematology, 1995